WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005037189) CYTOPLASMIC ACTIVITY OF RETINOID X RECEPTOR AND ITS REGULATION BY LIGANDS AND DIMERIZATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/037189    International Application No.:    PCT/US2004/026571
Publication Date: 28.04.2005 International Filing Date: 13.08.2004
IPC:
A61K 31/557 (2006.01)
Applicants: THE BURNHAM INSTITUTE [US/US]; 10901 North Torrey Pines Road, La Jolla, CA 92037 (US) (For All Designated States Except US).
ZHANG, Xiao-kun [CN/US]; (US) (For US Only).
CAO, Xihua [CN/US]; (US) (For US Only).
LIU, Wen [CN/US]; (US) (For US Only)
Inventors: ZHANG, Xiao-kun; (US).
CAO, Xihua; (US).
LIU, Wen; (US)
Agent: LANDES, Jeffrey; Catalyst Law Group, APC, 4330 La Jolla Village Drive, Suite 220, San Diego, CA 92122 (US)
Priority Data:
60/494,842 13.08.2003 US
Title (EN) CYTOPLASMIC ACTIVITY OF RETINOID X RECEPTOR AND ITS REGULATION BY LIGANDS AND DIMERIZATION
(FR) ACTIVITE CYTOPLASMIQUE DU RECEPTEUR RETINOIDE X ET SA REGULATION PAR DES LIGANDS ET SA DIMERISATION
Abstract: front page image
(EN)This invention relates to methods for identifying agents useful for treatment of diseases and pathological conditions affected by Retinoid X Receptor apoptosis. The invention also relates to methods for treating diseases and pathological conditions affected by RXR apoptosis. The invention includes compositions that are useful in the study and treatment of diseases and pathological conditions affected by RXR apoptosis.
(FR)L'invention porte sur des procédés d'identification d'agents utilisés pour le traitement de maladies et de pathologies associées à l'apoptose du récepteur rétinoïde X. L'invention porte également sur des méthodes de traitement de maladies et de pathologies associées par l'apoptose RXR. L'invention concerne des compositions que l'on utilise dans l'étude et le traitement de maladies et de pathologies associées à l'apoptose RXR.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)